Phase 3 Sophia Study of Margetuximab plus Chemotherapy Vs Trastuzumab plus Chemotherapy in Patients with Her2+Metastatic Breast Cancer After Prior Anti-Her2 Therapies: Second Interim Overall Survival Analysis

AuthID
 P-00S-87X
19
Author(s)
Im, SA
·
Cardoso, F
·
Cortes, J
·
Curigliano, G
·
Pegram, MD
·
Musolino, A
·
Bachelot, T
·
Wright, GS
·
De laurentiis, M
·
Kaufman, PA
·
Pluard, T
·
Ricci, F
·
Salazar, LG
·
Yardley, DA
·
Edlich, S
·
Hong, SY
·
Rock, E
·
Gradishar, WJ
1
Group Author(s)
SOPHIA Study Grp
Tipo de Documento
Abstract
Year published
2020
Publicado
in CANCER RESEARCH, ISSN: 0008-5472
Volume: 80, Número: 4
Conference
San Antonio Breast Cancer Symposium, Date: DEC 10-14, 2019, Location: San Antonio, TX
Indexing
Wos®
Google Scholar®
Publication Identifiers
Wos: WOS:000527012500025
Source Identifiers
ISSN: 0008-5472
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Citações
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info
At this moment we don't have any links to full text documens.

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2026 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service